BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11870382)

  • 1. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications.
    Hsu SC; Syu WJ; Sheen IJ; Liu HT; Jeng KS; Wu JC
    Hepatology; 2002 Mar; 35(3):665-72. PubMed ID: 11870382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen.
    Polson AG; Ley HL; Bass BL; Casey JL
    Mol Cell Biol; 1998 Apr; 18(4):1919-26. PubMed ID: 9528763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbranched rod-like RNA is required for RNA editing of hepatitis delta virus genotype 2 and genotype 4.
    Hsu CW; Hsu HY; Chen CH; Chao M
    Virus Res; 2023 Dec; 338():199239. PubMed ID: 37827303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants within the C-termini of L-HDAg that regulate hepatitis D virus replication and assembly.
    Guo H; Li Q; Li C; Hou Y; Ding Y; Liu D; Ni Y; Tang R; Zheng K; Urban S; Wang W
    JHEP Rep; 2024 Jan; 6(1):100961. PubMed ID: 38192534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.
    Gudima S; He Y; Meier A; Chang J; Chen R; Jarnik M; Nicolas E; Bruss V; Taylor J
    J Virol; 2007 Apr; 81(7):3608-17. PubMed ID: 17229685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization and X-ray diffraction analysis of the Trp/amber editing site of hepatitis delta virus (+)RNA: a case of rational design.
    MacElrevey C; Wedekind JE
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Dec; 61(Pt 12):1049-53. PubMed ID: 16511232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mathematical Analysis of HDV Genotypes: From Molecules to Cells.
    Zakh R; Churkin A; Totzeck F; Parr M; Tuller T; Etzion O; Dahari H; Roggendorf M; Frishman D; Barash D
    Mathematics (Basel); 2021 Sep; 9(17):. PubMed ID: 34540628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies.
    Patmore LA; van der Eijk AA; Janssen HLA; de Man RA; Sonneveld MJ
    J Hepatol; 2024 Jul; 81(1):e49-e50. PubMed ID: 38036005
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis of HDV: From virology to non-invasive markers of fibrosis.
    Majeed NA; Hitawala AA; Heller T; Koh C
    Liver Int; 2023 Aug; 43 Suppl 1(Suppl 1):31-46. PubMed ID: 36621853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, presentation, and therapeutic approaches for hepatitis D infections.
    Blaney H; Khalid M; Heller T; Koh C
    Expert Rev Anti Infect Ther; 2023 Feb; 21(2):127-142. PubMed ID: 36519386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong Replication Interference Between Hepatitis Delta Viruses in Human Liver Chimeric Mice.
    Giersch K; Hermanussen L; Volz T; Volmari A; Allweiss L; Sureau C; Casey J; Huang J; Fischer N; Lütgehetmann M; Dandri M
    Front Microbiol; 2021; 12():671466. PubMed ID: 34305837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis D infection: from initial discovery to current investigational therapies.
    Da BL; Heller T; Koh C
    Gastroenterol Rep (Oxf); 2019 Aug; 7(4):231-245. PubMed ID: 32477569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution and clinical impact of hepatitis B virus genome diversity.
    Revill PA; Tu T; Netter HJ; Yuen LKW; Locarnini SA; Littlejohn M
    Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):618-634. PubMed ID: 32467580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma.
    Puigvehí M; Moctezuma-Velázquez C; Villanueva A; Llovet JM
    JHEP Rep; 2019 Aug; 1(2):120-130. PubMed ID: 32039360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis Delta: Natural history and outcome.
    Romeo R
    Clin Liver Dis (Hoboken); 2013 Dec; 2(6):235-236. PubMed ID: 30992870
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus.
    Miao Z; Zhang S; Ma Z; Hakim MS; Wang W; Peppelenbosch MP; Pan Q
    J Viral Hepat; 2019 Jan; 26(1):183-190. PubMed ID: 30260538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of a whole-genome inter-clade recombination map of hepatitis delta virus suggest a host polymerase-driven and viral RNA structure-promoted template-switching mechanism for viral RNA recombination.
    Chao M; Wang TC; Lin CC; Yung-Liang Wang R; Lin WB; Lee SE; Cheng YY; Yeh CT; Iang SB
    Oncotarget; 2017 Sep; 8(37):60841-60859. PubMed ID: 28977829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.
    Nguyen HM; Sy BT; Trung NT; Hoan NX; Wedemeyer H; Velavan TP; Bock CT
    PLoS One; 2017; 12(4):e0175304. PubMed ID: 28403190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Nuclear Export Factors TAP and Aly Are Required for HDAg-L-mediated Assembly of Hepatitis Delta Virus.
    Huang HC; Lee CP; Liu HK; Chang MF; Lai YH; Lee YC; Huang C
    J Biol Chem; 2016 Dec; 291(50):26226-26238. PubMed ID: 27807029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte.
    Giersch K; Dandri M
    J Clin Transl Hepatol; 2015 Sep; 3(3):220-9. PubMed ID: 26623269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.